Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker use, dose titration, and safety registry in coronary heart disease
ChiCTR-RPC-17014094Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of carvedilol in coronary arteriosclerosis and acute coronary syndrome (ACS) (3 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Current application status of beta-blockers and Characteristics of the patient population. Started Dec 2017; status: recruiting.
02
Drugs
carvedilol
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-RPC-17014094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-RPC-17014094.